Citizens & Northern Corp Has $747,000 Stock Holdings in CVS Health Co. (NYSE:CVS)

Citizens & Northern Corp decreased its stake in shares of CVS Health Co. (NYSE:CVS) by 29.7% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 16,633 shares of the pharmacy operator’s stock after selling 7,036 shares during the quarter. Citizens & Northern Corp’s holdings in CVS Health were worth $747,000 at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. MidAtlantic Capital Management Inc. acquired a new position in shares of CVS Health during the 3rd quarter worth approximately $25,000. Ridgewood Investments LLC increased its holdings in CVS Health by 255.7% in the fourth quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock valued at $28,000 after purchasing an additional 450 shares during the period. Stonebridge Financial Group LLC bought a new stake in shares of CVS Health during the 4th quarter valued at about $28,000. Livelsberger Financial Advisory bought a new stake in CVS Health in the third quarter valued at $31,000. Finally, Legacy Investment Solutions LLC bought a new stake in CVS Health in the 3rd quarter valued at about $31,000. 80.66% of the stock is currently owned by institutional investors and hedge funds.

CVS Health Stock Down 1.0 %

CVS stock opened at $65.71 on Tuesday. CVS Health Co. has a 52 week low of $43.56 and a 52 week high of $80.75. The firm has a 50 day moving average of $51.11 and a 200 day moving average of $55.99. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80. The stock has a market capitalization of $82.84 billion, a PE ratio of 16.68, a price-to-earnings-growth ratio of 0.60 and a beta of 0.61.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share for the quarter, beating the consensus estimate of $0.89 by $0.30. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. Sell-side analysts forecast that CVS Health Co. will post 5.14 earnings per share for the current year.

CVS Health Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd were paid a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 4.05%. The ex-dividend date of this dividend was Thursday, January 23rd. CVS Health’s payout ratio is 72.68%.

Wall Street Analyst Weigh In

Several brokerages have recently commented on CVS. TD Cowen increased their price objective on CVS Health from $73.00 to $80.00 and gave the stock a “buy” rating in a research note on Monday, November 25th. Piper Sandler lowered their target price on CVS Health from $72.00 to $64.00 and set an “overweight” rating on the stock in a research note on Monday, November 25th. Mizuho decreased their price objective on CVS Health from $73.00 to $66.00 and set an “outperform” rating on the stock in a research note on Thursday, October 24th. Barclays boosted their price target on shares of CVS Health from $71.00 to $73.00 and gave the company an “overweight” rating in a research report on Thursday, February 13th. Finally, Evercore ISI increased their price target on shares of CVS Health from $60.00 to $65.00 and gave the stock an “outperform” rating in a report on Monday, January 27th. Four research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $70.28.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.